BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8621237)

  • 21. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
    Kogerman P; Sy MS; Culp LA
    Oncogene; 1997 Sep; 15(12):1407-16. PubMed ID: 9333016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of integrin alpha6 and beta4 enhances adhesion and proliferation of human retinal pigment epithelial cells on layers of porcine Bruch's membrane.
    Fang IM; Yang CH; Yang CM; Chen MS
    Exp Eye Res; 2009 Jan; 88(1):12-21. PubMed ID: 18955047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.
    Danen EH; van Kraats AA; Cornelissen IM; Ruiter DJ; van Muijen GN
    Biochem Biophys Res Commun; 1996 Sep; 226(1):75-81. PubMed ID: 8806594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.
    Rubenstein CS; Gard JMC; Wang M; McGrath JE; Ingabire N; Hinton JP; Marr KD; Simpson SJ; Nagle RB; Miranti CK; Warfel NA; Garcia JGN; Arif-Tiwari H; Cress AE
    Cancer Res; 2019 Sep; 79(18):4703-4714. PubMed ID: 31337652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion.
    Zhang L; Hill RP
    Cancer Res; 2007 Aug; 67(16):7789-97. PubMed ID: 17699784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development.
    Zent R; Bush KT; Pohl ML; Quaranta V; Koshikawa N; Wang Z; Kreidberg JA; Sakurai H; Stuart RO; Nigám SK
    Dev Biol; 2001 Oct; 238(2):289-302. PubMed ID: 11784011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
    Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
    Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver.
    Hangan D; Morris VL; Boeters L; von Ballestrem C; Uniyal S; Chan BM
    Cancer Res; 1997 Sep; 57(17):3812-7. PubMed ID: 9288792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells.
    Gong J; Wang D; Sun L; Zborowska E; Willson JK; Brattain MG
    Cell Growth Differ; 1997 Jan; 8(1):83-90. PubMed ID: 8993837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver.
    Hangan D; Uniyal S; Morris VL; MacDonald IC; von Ballestrem C; Chau T; Schmidt EE; Chambers AF; Groom AC; Chan BM
    Cancer Res; 1996 Jul; 56(13):3142-9. PubMed ID: 8674074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
    Cai DW; Mukhopadhyay T; Roth JA
    Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential modulation of integrin receptors and extracellular matrix laminin by transforming growth factor-beta 1 in rat alveolar epithelial cells.
    Kumar NM; Sigurdson SL; Sheppard D; Lwebuga-Mukasa JS
    Exp Cell Res; 1995 Dec; 221(2):385-94. PubMed ID: 7493638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
    Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
    Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin alpha6 cleavage: a novel modification to modulate cell migration.
    Pawar SC; Demetriou MC; Nagle RB; Bowden GT; Cress AE
    Exp Cell Res; 2007 Apr; 313(6):1080-9. PubMed ID: 17303120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells.
    Mukhopadhyay R; Theriault RL; Price JE
    Clin Exp Metastasis; 1999 Jun; 17(4):325-32. PubMed ID: 10545019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.
    Baird SK; Allan L; Renner C; Scott FE; Scott AM
    Clin Exp Metastasis; 2015 Jun; 32(5):507-16. PubMed ID: 25995078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells.
    Tsuchiya H; Sunayama C; Okada G; Matsuda E; Tomita K; Binder BR
    Anticancer Res; 1997; 17(1A):313-6. PubMed ID: 9066670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.